Clinical trial
Improving Hepatitis C Treatment in Injection Drug Users
NCT00148031 · State University of New York - Upstate Medical University, Other · Completed
Key facts
| NCT number | NCT00148031 |
|---|---|
| Title | Improving Hepatitis C Treatment in Injection Drug Users |
| Official title | Improving Hepatitis C Treatment in Injection Drug Users |
| Lead sponsor | State University of New York - Upstate Medical University, Other |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Hepatitis C, Liver Diseases, Drug Abuse, Alcoholism |
| Intervention type | Behavioral, Drug |
| Interventions | Pegylated Interferon and Ribavirin, Psychosocial, On-site (MMT Clinic) HCV evaluation and treatment, Off-site HCV evaluation and treatment |
| Enrollment | 111 |
| Start date | Sep 1, 2003 |
| Primary completion | Mar 1, 2007 |
| Completion | Mar 1, 2007 |
| First posted | Sep 7, 2005 |
| Last update posted | Apr 24, 2013 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: